Back to search

Article

Prolific Induction of IL-6 in Human Cells by SARS-CoV-2-derived Peptide is Attenuated by Recombinant Human Anti-inflammatory Cytokines made <i>in planta</i>

2021-09-14

Abstract excerpt

<h4>SUMMARY</h4> Development of efficient therapies for COVID-19 is the focus of intense research. The cytokine release syndrome was underlined as a culprit for severe outcomes in COVID-19 patients. Interleukin-6 (IL-6) plays a crucial role in human immune responses and elevated IL-6 plasma levels have been associated with the exacerbated COVID-19 pathology. Since non-structural protein 10 (NSP10) of SARS-CoV-2 h...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
34565aef-77cb-50fb-aa7a-3dcdc77768ec
DOI
10.1101/2021.09.14.460246
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Prolific Induction of IL-6 in Human Cells by SARS-CoV-2-derived Peptide is Attenuated by Recombinant Human Anti-inflammatory Cytokines made <i>in planta</i>DOI 10.1101/2021.09.14.460246
Select a neighboring publication to make it the new centre.